Indications and uses
To help the treatment of incurable diseases, various cancer, symptoms of atopy as immunomodulator due to immune deficiency.
To help the treatment of incurable diseases, various cancer, symptoms of atopy as immunomodulator due to immune deficiency.
Stimulant
Keep out of reach of children.
Calamus
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 61065-2001-1 | 2024-07-30 | C162847 | 48780-1 | ba0f9c33-50c6-a910-e053-dadaa90a0b85 | MIRAPHARM 22 |
| 61065-2001-1 | 2024-01-30 | C162847 | 48780-1 | ba0f9c33-50c6-a910-e053-dadaa90a0b85 | MIRAPHARM 22 |
| 61065-2001-1 | 2023-05-18 | C162847 | 48780-1 | ba0f9c33-50c6-a910-e053-dadaa90a0b85 | MIRAPHARM 22 |
| 61065-2001-1 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-50c6-a910-e053-dadaa90a0b85 | MIRAPHARM 22 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 61065-2001-1 | MIRAPHARM 22 | 1 in 1 BOX | CAPSULE | 1 | 5 | |
| 61065-2001-1 | MIRAPHARM 22 | 90 in 1 BOTTLE | CAPSULE | 90 | 5 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 61065-2001 | MIRAPHARM 22 (PANAX QUINQUEFOLIUS (RED GINSENG)) CAPSULE [MIRAPHARM., INC.] | 5 | Legacy NDC, 2 package rows | 20230519_ca9c6847-c2d7-46b6-9efd-d2864fb2b12a.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| PANAX QUINQUEFOLIUS WHOLE | ACTIVE INGREDIENT | 0P067WOA1X | 3 | |
| PANAX QUINQUEFOLIUS WHOLE | ACTIVE MOIETY | 0P067WOA1X | 3 | |
| ACORUS CALAMUS ROOT | INACTIVE INGREDIENT | XY1K7KIQ0F | 3 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 61065-2001 | 61065-2001-1 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ACORUS CALAMUS ROOT | XY1K7KIQ0F | IACT |
| PANAX QUINQUEFOLIUS WHOLE | 0P067WOA1X | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| fc0251d6-68ed-d86f-e053-6294a90aaac5 | ca9c6847-c2d7-46b6-9efd-d2864fb2b12a | 2023-05-18 | Warnings | fc0251d6-68ed-d86f-e053-6294a90aaac5 ca9c6847-c2d7-46b6-9efd-d2864fb2b12a |
Adverse event summaries are temporarily unavailable. Other product information remains available.